Positron Emitting Tracers in Pre-Clinical Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|5|2|90-98

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.5, Iss.2, 2012-04, pp. : 90-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 736-745

Bentham Science Publishers

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G   Reily Michael D   Baker J David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Pre-Clinical and Clinical Evaluation of Nuclear Tracers for the Molecular Imaging of Vulnerable Atherosclerosis: An Overview

By  

Current Medicinal Chemistry, Vol. 16, Iss. 12, 2009-04 ,pp. : 1499-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Zebrafish As a Genetic Model in Pre-Clinical Drug Testing and Screening

By  

Current Medicinal Chemistry, Vol. 20, Iss. 19, 2013-06 ,pp. : 2458-2466

Bentham Science Publishers

Access to resources Recommend Favorite